We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
Cap. Flow
+$512M
Cap. Flow %
1.04%
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$23.3M
2
BDX icon
Becton Dickinson
BDX
+$18.4M
3
AMZN icon
Amazon
AMZN
+$16.1M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$15.4M
5
JNJ icon
Johnson & Johnson
JNJ
+$14.6M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$48.1M
2
LVLT
Level 3 Communications Inc
LVLT
+$27.7M
3
KITE
Kite Pharma, Inc.
KITE
+$10.7M
4
PRXL
Parexel International Corp
PRXL
+$10.3M
5
CELG
Celgene Corp
CELG
+$10.2M

Sector Composition

Rank Sector Weight
1 Financials 16.9%
2 Technology 16.24%
3 Healthcare 13.01%
4 Industrials 10.83%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCB
1676
DELISTED
FCB Financial Holdings, Inc.
FCB
$1.83M ﹤0.01%
36,087
-5,866
-14% -$288K
NPKI
1677
NPK International
NPKI
$1.06B
$1.83M ﹤0.01%
212,632
+27,121
+15% +$246K
WSBC icon
1678
WesBanco
WSBC
$3.97B
$1.83M ﹤0.01%
44,965
-7,474
-14% -$305K
VTLE
1679
DELISTED
Vital Energy
VTLE
$1.82M ﹤0.01%
8,600
-815
-9% -$179K
TROX icon
1680
Tronox
TROX
$932M
$1.82M ﹤0.01%
88,768
+9,425
+12% +$230K
EGBN icon
1681
Eagle Bancorp
EGBN
$846M
$1.81M ﹤0.01%
31,333
-5,530
-15% -$354K
CALD
1682
DELISTED
Callidus Software, Inc.
CALD
$1.81M ﹤0.01%
63,225
-11,146
-15% -$304K
PCRX icon
1683
Pacira BioSciences
PCRX
$1.04B
$1.81M ﹤0.01%
39,592
-10,587
-21% -$420K
AROC icon
1684
Archrock
AROC
$6.27B
$1.8M ﹤0.01%
171,615
+22,392
+15% +$243K
TDOC icon
1685
Teladoc Health
TDOC
$1.22B
$1.8M ﹤0.01%
51,551
-9,404
-15% -$312K
RARE icon
1686
Ultragenyx Pharmaceutical
RARE
$2.45B
$1.79M ﹤0.01%
38,586
-7,707
-17% -$378K
ANIK icon
1687
Anika Therapeutics
ANIK
$258M
$1.79M ﹤0.01%
33,181
+4,836
+17% +$268K
SNEX icon
1688
StoneX
SNEX
$9.26B
$1.79M ﹤0.01%
212,924
+23,997
+13% +$197K
SSTK icon
1689
Shutterstock
SSTK
$198M
$1.79M ﹤0.01%
41,555
+4,893
+13% +$191K
CUBI icon
1690
Customers Bancorp
CUBI
$2.66B
$1.79M ﹤0.01%
68,755
+9,799
+17% +$278K
ECHO
1691
DELISTED
Echo Global Logistics, Inc.
ECHO
$1.77M ﹤0.01%
63,305
+8,345
+15% +$200K
SEDG icon
1692
SolarEdge
SEDG
$2.51B
$1.77M ﹤0.01%
47,173
+18,572
+65% +$639K
RGP icon
1693
Resources Connection
RGP
$151M
$1.77M ﹤0.01%
114,457
+2,735
+2% +$42.2K
PNK
1694
DELISTED
Pinnacle Entertainment Inc.
PNK
$1.77M ﹤0.01%
54,024
-9,328
-15% -$260K
PEGA icon
1695
Pegasystems
PEGA
$5.02B
$1.76M ﹤0.01%
74,524
-12,600
-14% -$338K
TRTN
1696
DELISTED
Triton International Limited
TRTN
$1.75M ﹤0.01%
46,804
-5,443
-10% -$209K
PPC icon
1697
Pilgrim's Pride
PPC
$6.51B
$1.75M ﹤0.01%
56,221
-1,505
-3% -$49.1K
TNET icon
1698
TriNet
TNET
$3.02B
$1.74M ﹤0.01%
39,224
-7,039
-15% -$282K
HT
1699
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1.74M ﹤0.01%
99,942
+12,305
+14% +$220K
MED icon
1700
Medifast
MED
$109M
$1.74M ﹤0.01%
24,902
+3,071
+14% +$204K
66 67
68
69 70

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
  • RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
  • RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
  • RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
  • RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.

Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.